www.fdanews.com/articles/189683-cepheids-hepatitis-b-viral-load-test-gains-ce-mark
Cepheid’s Hepatitis B Viral Load Test Gains CE Mark
December 27, 2018
Cepheid has received the CE Mark for a rapid molecular assay, the Xpert HBV Viral Load Test, which measures viral loads of Hepatitis B in patients.
Using Cepheid’s GeneXpert system, the test measures a patient’s HBV DNA levels via plasma or serum samples and produces quantitative results in less than an hour.
The test can be used for predicting the likely development of a disease and to measure a patient’s response to antiviral treatment.